Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strainsB Wu, M Shenoy, E Goluszko, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1996
IFN-alpha therapy is effective in suppressing the clinical experimental myasthenia gravisC Deng, E Goluszko, S Baron, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravisB Balasa, C Deng, J Lee, et al.Clinical Immunology and Immunopathology|July 1, 1998
The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravisV Dedhia, E Goluszko, B Wu, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1981
Genetic control of experimental autoimmune myasthenia gravis in mice. II. Lymphocyte proliferative response to acetylcholine receptor is dependent on Lyt-1+23- cellsP Christadoss, C J Krco, V A Lennon, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1982
Genetic control of experimental autoimmune myasthenia gravis in mice. III. Ia molecules mediate cellular immune responsiveness to acetylcholine receptorsP Christadoss, V A Lennon, C J Krco, et al.Neurology|December 30, 2004
Etanercept treatment in corticosteroid-dependent myasthenia gravisJ Rowin, M N Meriggioli, E Tüzün, et al.Cellular Immunology|July 15, 1983
Deficient T-cell mitogen response in murine experimental autoimmune myasthenia gravis: a defect in the adherent cell populationP Christadoss, M Dauphinee, J Lindstrom, et al.Journal of Neuroimmunology|November 7, 2000
Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChRM A Poussin, E Goluszko, T K Hughes, et al.Scandinavian Journal of Rheumatology. Supplement|January 1, 1988
Abnormalities of T cell activation in the rheumatoid synovium detected with monoclonal antibodies to CD3N Talal, Z Tovar, M J Dauphinee, et al.Pageof 5